CapsoVision (NASDAQ:CV – Get Free Report) and Utah Medical Products (NASDAQ:UTMD – Get Free Report) are both small-cap healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their risk, analyst recommendations, earnings, dividends, profitability, institutional ownership and valuation.
Insider and Institutional Ownership
69.6% of Utah Medical Products shares are owned by institutional investors. 2.3% of CapsoVision shares are owned by company insiders. Comparatively, 8.0% of Utah Medical Products shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Earnings and Valuation
This table compares CapsoVision and Utah Medical Products”s revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CapsoVision | $13.55 million | 23.16 | -$25.32 million | ($0.47) | -13.34 |
| Utah Medical Products | $38.52 million | 6.08 | $11.29 million | $3.34 | 22.04 |
Utah Medical Products has higher revenue and earnings than CapsoVision. CapsoVision is trading at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
CapsoVision has a beta of -2.34, indicating that its stock price is 334% less volatile than the S&P 500. Comparatively, Utah Medical Products has a beta of 0.38, indicating that its stock price is 62% less volatile than the S&P 500.
Analyst Ratings
This is a summary of recent recommendations and price targets for CapsoVision and Utah Medical Products, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CapsoVision | 1 | 1 | 2 | 0 | 2.25 |
| Utah Medical Products | 0 | 1 | 0 | 0 | 2.00 |
CapsoVision currently has a consensus price target of $9.50, indicating a potential upside of 51.52%. Given CapsoVision’s stronger consensus rating and higher possible upside, analysts plainly believe CapsoVision is more favorable than Utah Medical Products.
Profitability
This table compares CapsoVision and Utah Medical Products’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CapsoVision | -214.74% | -177.85% | -135.07% |
| Utah Medical Products | 30.48% | 8.83% | 8.59% |
Summary
Utah Medical Products beats CapsoVision on 10 of the 14 factors compared between the two stocks.
About CapsoVision
CapsoVision develops medical technology for capsule endoscopy, a method of examining the digestive tract using a swallowable camera. Its products are designed to help clinicians visualize the small intestine as part of diagnostic evaluation. The company’s CapsoCam Plus system uses a swallowable capsule with multiple cameras to capture panoramic images as it moves through the small intestine. Images are stored in the capsule and later retrieved for review using the company’s supporting hardware and software.
About Utah Medical Products
Utah Medical Products, Inc. develops, manufactures and markets medical devices, with a focus on disposable products used in obstetrics, gynecology and neonatal care. Its offerings include devices and accessories for fetal monitoring, labor and delivery, newborn care and related clinical procedures. Founded in 1978 and headquartered in Midvale, Utah, the company also serves other areas of healthcare, including surgery and emergency care. Its products reach customers in the United States and international markets through a combination of direct sales and distribution channels.
Receive News & Ratings for CapsoVision Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CapsoVision and related companies with MarketBeat.com's FREE daily email newsletter.
